CB-010
Showing 26 - 50 of 780
Leptomeningeal Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain Trial in United States
Recruiting
- Leptomeningeal Neoplasm
- +6 more
- Sapanisertib
- Telaglenastat Hydrochloride
-
Duarte, California
- +6 more
Dec 29, 2022
Persistent, Recurrent, or Metastatic Cervical Cancer Trial in Shanghai (GLS-010, Placebo, paclitaxel)
Not yet recruiting
- Persistent, Recurrent, or Metastatic Cervical Cancer
- GLS-010
- +5 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Hospital
Apr 4, 2023
Type 1 Diabetes Trial in Edmonton (Islet isolation using BMX-010)
Completed
- Type 1 Diabetes
- Islet isolation using BMX-010
-
Edmonton, Alberta, CanadaUniversity of Alberta
May 5, 2022
PTSD, Intrusive Traumatic Memories Trial in Lausanne (A single-session behavioral intervention composed of a brief evocation of
Recruiting
- Posttraumatic Stress Disorder
- Intrusive Traumatic Memories
- A single-session behavioral intervention composed of a brief evocation of the childbirth memory followed by a Tetris gameplay
-
Lausanne, Vaud, SwitzerlandAntje Horsch
Jul 15, 2022
Metastatic Solid Tumor Cancer Trial in Caen, Paris, Villejuif (Dose escalation, first-in-human phase I clinical trial with an
Recruiting
- Metastatic Solid Tumor Cancer
- Dose escalation, first-in-human phase I clinical trial with an Expansion phase
-
Caen, France
- +2 more
Oct 11, 2022
Stroke, Ischemic, Quadrantanopia, Hemianopsia, Homonymous Trial in Rochester (Virtual Reality Driving Task)
Not yet recruiting
- Stroke, Ischemic
- +10 more
- Virtual Reality Driving Task
-
Rochester, New YorkUniversity of Rochester
Sep 22, 2023
Pulmonary Fibrosis Trial in Worldwide (BMS-986278 Placebo, BMS-986278)
Active, not recruiting
- Pulmonary Fibrosis
- BMS-986278 Placebo
- BMS-986278
-
Birmingham, Alabama
- +118 more
Dec 3, 2022
Stargardt Disease Trial in Miami, McAllen (Gene Therapy-vMCO-010)
Active, not recruiting
- Stargardt Disease
- Gene Therapy-vMCO-010
-
Miami, Florida
- +1 more
Nov 28, 2022
Dental Caries Trial in Araçatuba (Applications of self-etching adhesives and dental restorations)
Completed
- Dental Caries
- Applications of self-etching adhesives and dental restorations
-
Araçatuba, Sao Paulo, BrazilCristiane Duque
Jan 4, 2023
Secondary Progressive Multiple Sclerosis (SPMS) Trial in Tel Aviv (SCM-010)
Not yet recruiting
- Secondary Progressive Multiple Sclerosis (SPMS)
- SCM-010
-
Tel Aviv, IsraelTel Aviv Medical Center
Oct 26, 2022
COVID-19 Trial in Worldwide (Dapagliflozin 10 milligram (mg), Placebo)
Completed
- COVID-19
- Dapagliflozin 10 milligram (mg)
- Placebo
-
Fairhope, Alabama
- +94 more
May 13, 2022
Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer Trial in United States (Paclitaxel, CB-839)
Completed
- Triple Negative Breast Cancer
- TNBC - Triple-Negative Breast Cancer
-
Birmingham, Alabama
- +24 more
Sep 19, 2022
Systemic Lupus Erythematosus Trial in Worldwide (Afimetoran, Placebo)
Recruiting
- Systemic Lupus Erythematosus
- Afimetoran
- Placebo
-
Fullerton, California
- +123 more
Aug 12, 2022
Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT) Trial in Worldwide (Edoxaban, Standard of Care)
Completed
- Venous Thromboembolism (VTE)
- +2 more
- Edoxaban
- Standard of Care
-
Tucson, Arizona
- +139 more
Jun 28, 2022
Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Common Bile Duct Tumors Trial in Rotterdam (Endoscopic Ultrasound
Recruiting
- Hilar Cholangiocarcinoma
- +4 more
- Endoscopic Ultrasound registration
-
Rotterdam, Zuid-Holland, NetherlandsErasmus University Medical Center
Jan 11, 2023
Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in China (ATG-010 and ATG-008)
Recruiting
- Relapsed/Refractory Diffuse Large B-cell Lymphoma
- ATG-010 and ATG-008
-
Chongqing, Chongqing, China
- +5 more
Sep 2, 2022
Idiopathic Hypersomnia, Excessive Daytime Sleepiness Trial in United States (pitolisant)
Enrolling by invitation
- Idiopathic Hypersomnia
- Excessive Daytime Sleepiness
-
Peoria, Arizona
- +57 more
Nov 10, 2022
Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham
Active, not recruiting
- Retinitis Pigmentosa
- +6 more
- Gene Therapy Product-vMCO-010
- Sham Injection
-
Beverly Hills, California
- +6 more
Jul 13, 2022
Chiari Malformation, Type 1 Trial in Assiut (posterior fossa craniectomy with or without duraplasty)
Recruiting
- Chiari Malformation, Type 1
- posterior fossa craniectomy with or without duraplasty
-
Assiut, EgyptAssiut University
Sep 6, 2023
Clostridium Difficile Infection Trial (CB-183,315, Vancomycin, Placebo)
Sickle Cell Disease, Umbilical Cord Blood, Hematopoietic Cell Proliferation Trial in Palo Alto, San Francisco (ECT-001-CB
Withdrawn
- Sickle Cell Disease
- +2 more
- ECT-001-CB (UM171-Expanded Cord Blood Transplant)
-
Palo Alto, California
- +1 more
Jun 29, 2022
Relapsed or Refractory Multiple Myeloma Trial in China (SVd (Selinexor+Bortezomib+dexamethasone), Vd (Bortezomib+dexamethasone))
Recruiting
- Relapsed or Refractory Multiple Myeloma
- SVd (Selinexor+Bortezomib+dexamethasone)
- Vd (Bortezomib+dexamethasone)
-
Hefei, Anhui, China
- +33 more
Aug 14, 2022
Dry Age-related Macular Degeneration Trial in Rome (Intravitreal injection of CB-PRP)
Recruiting
- Dry Age-related Macular Degeneration
- Intravitreal injection of CB-PRP
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023
Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Steroid Refractory Graft Versus Host Disease
- Cellular Therapy
- Ruxolitinib
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022